Unraveling the Biomedical Potential of Bacterial Cellulose: A Review of Current Research and Future Directions

  • Unique Paper ID: 167785
  • Volume: 11
  • Issue: 4
  • PageNo: 401-410
  • Abstract:
  • Bacterial cellulose (BC) is a type of organic material produced by some bacteria, such as Novacetimonas, Gluconacetobacter, and Komagataeibacter, that is obtained through the process of microbial fermentation. BC has demonstrated itself to be a highly flexible biomaterial with outstanding potential in a range of biomedical applications. Its unique properties, which include high water-holding capacity, biodegradability, mechanical strength, and biocompatibility, make it an appealing choice for a range of applications, such as wound healing, tissue engineering, and drug delivery. This study examines the latest developments in the use of BC in biomedical fields, emphasizing its use in cancer therapies, epithelization, nerve and urethral implants, dermal applications, wound healing, artificial corneas and retinas, drug delivery, anesthesia, and analgesics. In terms of encouraging tissue regeneration, lowering inflammation, and improving general patient outcomes, BC has shown encouraging results. To fully explore its potential and optimize the approaches and strategies for various medical conditions, more clinical research is necessary. To sum up, BC represents a valuable biotechnological response to clinical challenges, and ongoing research holds the promise of expanding its role in improving patient healthcare.

Related Articles